IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Altium Capital Management LLC

Q1 2022 Holdings

Filed 2022-05-16 | 118 holdings | $24.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Insmed Inc(INSM)COM PAR $.01457669307$6.3K268,0000.0%
Quidel CorpCOM74838J101$6.3K56,0000.0%
Dexcom Inc(DXCM)COM252131107$6.4K12,5000.0%
Keros Therapeutics Inc(KROS)COM492327101$6.9K126,0000.0%
Pepperlime Health Acqustn CoUNIT 99/99/9999G70021129$7.2K735,0000.0%
Chinook Therapeutics Inc(290A)COM16961L106$8.9K545,0000.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$9.1K386,0000.0%
Bellus Health Inc New(BLU)COM NEW07987C204$10.0K1,450,0060.0%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$11.6K2,496,5240.0%
Protagonist Therapeutics Inc(PTGX)CallCOM74366E102$11.8K5,0000.0%
Achieve Life Sciences Inc(ACHV)COM004468500$924.0K122,0003.7%
Cytomx Therapeutics Inc(CTMX)COM23284F105$1.8M663,8007.1%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$1.9M66,1967.7%
Altimmune Inc(ALT)COM NEW02155H200$2.0M322,0007.9%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$2.2M66,0009.0%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$4.5M204,00018.0%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$5.3M120,00021.2%
Adma Biologics Inc(ADMA)COM000899104$6.0M3,300,00024.3%
PreviousPage 3 of 3